$52.80
0.22 (+0.42%)
Novartis AG (ADR) (NVS)
CAPS Rating:
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
Recs
Defensive LT play in tumultuous times. Has weathered the storm to date very nicely. Solid margins and revenue growth over the years and well into the current economic crisis. Plus a decent dividend. Can't ask for much more nowadays.